Einfluss der Fallzahlen auf die Komplikationsrate in der Hüftendoprothetik: eine Analyse bundesweiter AOK-Daten

Abstract

Introduction

Due to demographic changes and the associated expected increases in the number of primary hip arthroplasty and revision surgeries, it is important to identify factors that can reduce complications and revisions. One such factor is the hospital volume. Studies have shown that hospitals with higher case numbers have lower morbidity and complication rates. Most studies are based on registry data, which is often incomplete and does not include patient-specific factors.

Methods

In this study, nationwide pseudonymised inpatient data and insurance records from the Allgemeine Ortskrankenkasse (AOK) from 2017 to 2019 in patients with primary hip arthroplasty were analysed. To examine the impact of hospital case volume on outcomes, five volume categories were created (I: 1–49, II: 50–99, III: 100–199, IV: 200–399, V: ≥ 400 operations per year). The endpoints considered were 90-day mortality, 1-year revision surgeries, surgical complications (90 days and 365 days), periprosthetic femur fractures (90 days), and serious general complications during the hospital stay. The effect of hospital volume on outcomes was analysed using multiple logistic regression, considering patient-specific factors.

Results

The analysis of 137,494 cases from 993 clinics shows a statistically significant relationship between the case number group and the frequency of revision surgeries, surgical complications, periprosthetic femur fractures, and general complications. Clinics with fewer than 50 cases per year showed an increased risk of 65% to 88% for these endpoints compared to the group with the highest case numbers. For the endpoint mortality, a dichotomous consideration of the volume categories also shows a significant influence by the hospital volume.

Conclusion

The study shows that higher case volume in primary hip arthroplasty is associated with lower complication rates, even when considering patient-specific factors. These findings underline the importance of case numbers as a factor for improving the quality of care in hip arthroplasty.

Schlüsselwörter

Hüftendoprothetik - periprothetische Infektion - Hospitals, High-Volume - Hospitals, Low-Volume - postoperative Komplikationen

Publication History

Received: 31 October 2024

Accepted after revision: 12 February 2025

Article published online:
18 March 2025

• Literatur

• 1 Grimberg A, Lützner J, Melsheimer O. et al. Endoprothesenregister Deutschland (EPRD) Jahresbericht 2023. Berlin 2023 Accessed February 28, 2025 at: https://www.eprd.de/fileadmin/user_upload/Dateien/Publikationen/Berichte/Jahresbericht2023-Status5_2023-10-24_F.pdf
• 2 Institut für Qualität und Transparenz im Gesundheitswesen (IQTIG). Hüftgelenkversorgung: Hüftendoprothesenversorgung. Bundesauswertung zum Erfassungsjahr 2022. Accessed February 28, 2025 at: https://iqtig.org/downloads/auswertung/2022/hgvhep/DeQS_HGV-HEP_2022_BUAW_Bund_2023-07-20.pdf
• 3 Pilz V, Hanstein T, Skripitz R. Projections of primary hip arthroplasty in Germany until 2040. Acta Orthop 2018; 89: 308-313
• 4 Klug A, Pfluger DH, Gramlich Y. et al. Future burden of primary and revision hip arthroplasty in Germany: a socio-economic challenge. Arch Orthop Trauma Surg 2021; 141: 2001-2010
• 5 Katz JN, Losina E, Barrett J. et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am 2001; 83: 1622-1629
• 6 Siddiqi A, Alamanda VK, Barrington JW. et al. Effects of Hospital and Surgeon Volume on Patient Outcomes After Total Joint Arthroplasty: Reported From the American Joint Replacement Registry. J Am Acad Orthop Surg 2022; 30: e811-e821
• 7 Soohoo NF, Farng E, Lieberman JR. et al. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res 2010; 468: 2363-2371
• 8 Singh JA, Kwoh CK, Boudreau RM. et al. Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database. Arthritis Rheum 2011; 63: 2531-2539
• 9 Glassou EN, Hansen TB, Makela K. et al. Association between hospital procedure volume and risk of revision after total hip arthroplasty: a population-based study within the Nordic Arthroplasty Register Association database. Osteoarthritis Cartilage 2016; 24: 419-426
• 10 Dy CJ, Bozic KJ, Pan TJ. et al. Risk factors for early revision after total hip arthroplasty. Arthritis Care Res (Hoboken) 2014; 66: 907-915
• 11 Martineau P, Filion KB, Huk OL. et al. Primary hip arthroplasty costs are greater in low-volume than in high-volume Canadian hospitals. Clin Orthop Relat Res 2005; (437) 152-156
• 12 Mitsuyasu S, Hagihara A, Horiguchi H. et al. Relationship between total arthroplasty case volume and patient outcome in an acute care payment system in Japan. J Arthroplasty 2006; 21: 656-663
• 13 Styron JF, Koroukian SM, Klika AK. et al. Patient vs provider characteristics impacting hospital lengths of stay after total knee or hip arthroplasty. J Arthroplasty 2011; 26: 1418-1426.e1–2
• 14 Ramkumar PN, Navarro SM, Frankel WC. et al. Evidence-Based Thresholds for the Volume and Length of Stay Relationship in Total Hip Arthroplasty: Outcomes and Economies of Scale. J Arthroplasty 2018; 33: 2031-2037
• 15 Steinbrück A, Grimberg A, Melsheimer O. et al. Einfluss der institutionellen Erfahrung auf die Ergebnisse in Hüft- und Knietotalendoprothetik: Eine Analyse aus dem Endoprothesenregister Deutschland (EPRD). Orthopade 2020; 49: 808-814
• 16 Bundesministerium für Gesundheit. Daten des Gesundheitswesens. Versicherungsschutz in Kranken- und Pflegeversicherung 2016. Accessed February 28, 2025 at: https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/5_Publikationen/Gesundheit/Broschueren/161019_BMG_DdGW.pdf
• 17 Wissenschaftliches Institut der AOK (WIdA). QSR-Verfahren: Indikatorenhandbuch 2021. Berlin 2021 Accessed February 28, 2025 at: https://qualitaetssicherung-mit-routinedaten.de/imperia/md/qsr/methoden/indikatorenhandbuch_2021_final_1.pdf
• 18 Institut für Qualität und Transparenz im Gesundheitswesen (IQTIG). Hüftendoprothesenversorgung. Bundesauswertung zum Erfassungsjahr 2019. Accessed February 28, 2025 at: https://iqtig.org/downloads/auswertung/2019/hep/QSKH_HEP_2019_BUAW_V02_2020-07-14.pdf
• 19 Institut für Qualität und Transparenz im Gesundheitswesen (IQTIG). Hüftendoprothesenversorgung. Bundesauswertung zum Erfassungsjahr 2018. Accessed February 28, 2025 at: https://iqtig.org/downloads/auswertung/2018/hep/QSKH_HEP_2018_BUAW_V02_2019-07-23.pdf
• 20 Institut für Qualität und Transparenz im Gesundheitswesen (IQTIG). Hüftendoprothesenversorgung. Bundesauswertung zum Erfassungsjahr 2017. Accessed March 13, 2025 at: https://iqtig.org/downloads/berichte/2017/IQTIG_Qualitaetsreport-2017_2018_09_21.pdf
• 21 Ondeck NT, Bohl DD, Bovonratwet P. et al. Discriminative Ability of Elixhauser’s Comorbidity Measure is Superior to Other Comorbidity Scores for Inpatient Adverse Outcomes After Total Hip Arthroplasty. J Arthroplasty 2018; 33: 250-257
• 22 Elixhauser A, Steiner C, Harris DR. et al. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27
• 23 Quan H, Sundararajan V, Halfon P. et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-1139
• 24 Schräder P, Rath T. Mindestmengen in der Hüftgelenksendoprothetik bei Coxarthrose und Schenkelhalsfraktur – Evidenzbericht und Modellrechnung zur Auswirkung auf die flächendeckende Versorgung. Z Orthop Unfall 2007; 145: 281-290
• 25 Doro C, Dimick J, Wainess R. et al. Hospital volume and inpatient mortality outcomes of total hip arthroplasty in the United States. J Arthroplasty 2006; 21: 10-16
• 26 Osmanski-Zenk K, Klinder A, Malzahn J. et al. 3-Jahres-Revisionsrate von zertifizierten EndoProthetikZentren nach EndoCert Risikoadjustierte Analyse der Ergebnisqualität und Vergleich mit anderen Qualitätssicherungssystemen. Orthopadie (Heidelb) 2023; 52: 320-331
• 27 Hoffmann F, Icks A. [Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor]. Gesundheitswesen 2012; 74: 291-297